Cravings returning even during a strict cut?

[Anabolix]

Cravings returning even during a strict cut?
Investigating satiety hormones and appetite suppression pathways.​

Why cravings come back despite discipline ?

Many people assume cravings are purely psychological. In reality they are largely hormonal. During a prolonged calorie deficit the body actively pushes back. Fat loss lowers leptin, insulin, and thyroid output while increasing hunger signaling. Even with perfect compliance your brain interprets sustained dieting as a threat and starts amplifying food seeking behavior. This is not weakness. It is physiology.

Cagrilintide enters this discussion because it targets a different satiety axis than GLP-1 drugs and addresses some of the gaps people feel when cravings creep back in.

What Cagrilintide actually is

Cagrilintide is a long-acting amylin analogue. Amylin is a peptide hormone co-secreted with insulin from pancreatic beta cells. While insulin manages blood glucose, amylin’s primary role is appetite regulation and meal termination.

In obesity and chronic dieting states, amylin signaling is often blunted. You can be eating fewer calories, yet your brain never fully receives the “meal complete” signal. This leads to persistent thoughts about food, grazing behavior, and loss of dietary control over time.

Amylin’s role in appetite control

Amylin works through central nervous system pathways, particularly the area postrema and nucleus tractus solitarius in the brainstem. Its effects include:

• Slowing gastric emptying, increasing fullness duration
• Reducing post-meal glucagon secretion
• Enhancing satiety signaling independent of blood glucose
• Suppressing reward-driven eating behavior

Unlike leptin, which becomes resistant in obesity, amylin retains activity even in insulin-resistant states. This makes it particularly relevant during aggressive cuts or long dieting phases.

Why GLP-1 alone can stop working mentally

GLP-1 agonists mainly act by:

• Increasing insulin secretion
• Delaying gastric emptying
• Reducing appetite via hypothalamic pathways

They work very well early on. However, many users report that after weeks or months, hunger thoughts and cravings slowly return even though physical hunger remains low. This happens because GLP-1 does not fully address meal termination and conditioned eating behavior.

You feel full, yet still want to eat.

Amylin signaling fills this gap by reinforcing the brain’s perception that eating has concluded, not just that the stomach is full.

Cagrilintide and craving suppression

Cagrilintide has shown strong effects on:

• Reduction in food preoccupation
• Decreased reward-based eating
• Improved dietary adherence over time
• Lower desire to snack between meals

This makes it particularly effective for individuals who are already lean, already disciplined, yet struggling with intrusive cravings during the later stages of a cut.

It does not rely on blood sugar swings or insulin spikes to work. The effect is neurological and behavioral.

Why cravings often spike late in a cut

As body fat drops:

• Leptin falls sharply
• Ghrelin rises
• Dopamine sensitivity to food increases
• Stress hormones increase

This combination makes food more mentally rewarding and harder to ignore. You are not “hungrier” in a stomach sense. You are more food-focused.

Cagrilintide directly dampens this drive by enhancing satiety signaling at the brainstem level, reducing the urgency and salience of food cues.

Cagrilintide vs Semaglutide mindset effects

Semaglutide often produces appetite suppression that feels physical. You get full quickly.

Cagrilintide tends to produce appetite suppression that feels mental. Food loses its pull.

When combined, users often report the most complete appetite control: early fullness from GLP-1 and lasting satiety from amylin signaling.

This explains why cravings can return on GLP-1 monotherapy yet disappear when amylin activity is restored.

Diet fatigue and adherence

Diet failure rarely comes from hunger alone. It comes from decision fatigue. Constantly saying no drains willpower.

By reducing background food noise, Cagrilintide lowers cognitive load. You are not fighting cravings all day. Compliance becomes passive again, similar to how the first weeks of a cut feel.

This is especially relevant for advanced dieters who cannot rely on motivation alone.

Who benefits most

Cagrilintide is most useful for:

• Lean individuals pushing deeper fat loss
• Long-term dieters experiencing mental burnout
• GLP-1 users with returning cravings
• Athletes needing dietary precision
• Individuals with strong reward-driven eating patterns

It is less about appetite elimination and more about appetite regulation.

Key takeaway

If cravings are returning during a strict cut, the issue is not discipline. It is missing satiety signaling.

Cagrilintide addresses a different hormonal pathway than GLP-1 drugs, targeting meal completion and food reward rather than stomach fullness alone.

For those deep into a diet, that distinction matters more than calories ever will.